LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.06 | 770.25 | 2276 | 3106 | 0.7328 | 0.7136 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.28 | 770.25 | 1801 | 3392 | 0.5308 | 0.4875 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.28 | 770.25 | 2402 | 3392 | 0.7080 | 0.7018 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.50 | 770.25 | 1885 | 3712 | 0.5078 | 0.4836 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.50 | 770.25 | 2530 | 3712 | 0.6816 | 0.6891 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 770.25 | 1974 | 4086 | 0.4831 | 0.4784 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 770.25 | 2663 | 4086 | 0.6517 | 0.6741 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.95 | 770.25 | 2084 | 4543 | 0.4586 | 0.4751 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.95 | 770.25 | 2816 | 4543 | 0.6197 | 0.6591 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.17 | 770.25 | 2181 | 5010 | 0.4353 | 0.4700 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.17 | 770.25 | 2955 | 5010 | 0.5898 | 0.6449 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.39 | 770.25 | 2308 | 5404 | 0.4271 | 0.4776 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.39 | 770.25 | 3158 | 5404 | 0.5843 | 0.6520 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.61 | 770.25 | 2474 | 5813 | 0.4256 | 0.4921 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.61 | 770.25 | 3357 | 5813 | 0.5775 | 0.6567 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.83 | 770.25 | 2626 | 6223 | 0.4220 | 0.5021 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.83 | 770.25 | 3520 | 6223 | 0.5656 | 0.6555 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.05 | 770.25 | 2746 | 6629 | 0.4142 | 0.5058 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.05 | 770.25 | 3697 | 6629 | 0.5577 | 0.6571 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.27 | 770.25 | 2861 | 7058 | 0.4053 | 0.5077 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.27 | 770.25 | 3971 | 7058 | 0.5626 | 0.6706 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.49 | 770.25 | 3014 | 7555 | 0.3989 | 0.5131 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.49 | 770.25 | 4173 | 7555 | 0.5523 | 0.6702 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 56.71 | 770.25 | 3205 | 8001 | 0.4005 | 0.5253 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 56.71 | 770.25 | 4436 | 8001 | 0.5544 | 0.6794 | MN20160304_L02 | K11 |